CEO Francis Creighton presented the ThromBot™ technology at the MedTech Innovator Radar Forum 2026.

We are proud to share that our Co-founders attended the MedTech Innovator Radar Forum held in Manhanttan Beach, CA from April 7-9, 2026 where they presented UNandUP’s ThromBot™, our radial-friendly novel technology advancing the treatment of distal occlusions.

The Radar Forum is the validation stage of MTI’s accelerator evaluation process, bringing curated, high-potential medtech companies to engage directly with strategics, investors, and experts before final program selection.

This unique platform convenes stakeholders shaping the regulation, adoption, and investment of innovative medical technologies in highly interactive, small-group settings.

With curated 1:1 conversations between 140+ vetted startups and over 200 decision-makers, The MTI Radar Forum is where meaningful dialogue turns into real momentum and UNandUP is proud to have been a part.

UNandUP’s CEO and Co-founder Francis Creighton presenting ThromBot™ at the forum.

A display of UNandUP’s ThromBot™ Technology at The MTI Radar Forum 2026

UNandUP Co-founder Peter Finley at the MTI Radar Forum 2026

UNandUP’s Co-founders, Francis Creighton and Peter Finley at the Partnering Lounge (Source: MTI RadarForum2026 LinkedIn)